STAT6/NN
Gene/NN
Polymorphisms/NNS
in/IN
Allergic/JJ
Rhinitis/NN
./.
====================
T/NN
helper-type/NN
2/CD
cytokines/NNS
,/,
such/JJ
as/IN
IL-4/NN
and/CC
IL-13/NN
,/,
may/MD
====================
play/VBP
a/DT
central/JJ
role/NN
in/IN
allergic/JJ
diseases/NNS
./.
====================
The/DT
protein/NN
known/VBN
as/IN
signal/JJ
transducers/NNS
and/CC
activators/NNS
of/IN
transcription/NN
6/CD
(/(
STAT6/NN
)/)
is/VBZ
a/DT
key/JJ
transcription/NN
factor/NN
involved/VBN
in/IN
both/DT
IL-4-/NN
and/CC
-13-mediated/JJ
biological/JJ
responses/NNS
./.
====================
Two/CD
polymorphisms/NNS
of/IN
the/DT
STAT/NN
6/CD
gene/NN
(/(
exon/NN
1/CD
and/CC
G2964A/NN
variant/JJ
)/)
have/VBP
been/VBN
found/VBN
./.
====================
We/PRP
investigated/VBD
whether/IN
these/DT
STAT6/NN
gene/NN
polymorphisms/NNS
were/VBD
associated/VBN
with/IN
allergic/JJ
rhinitis/NN
./.
====================
Blood/NN
samples/NNS
for/IN
genetic/JJ
analysis/NN
were/VBD
obtained/VBN
from/IN
285/CD
individuals/NNS
with/IN
allergic/JJ
rhinitis/NN
and/CC
from/IN
271/CD
healthy/JJ
subjects/NNS
without/IN
atopic/JJ
disease/NN
./.
====================
The/DT
G2964A/NN
variant/JJ
of/IN
the/DT
STAT6/NN
gene/NN
was/VBD
genotyped/VBN
using/VBG
PCR-RFLP/NN
analysis/NN
./.
====================
The/DT
GT/NN
repeat/NN
polymorphism/NN
in/IN
exon/NN
1/CD
of/IN
the/DT
STAT6/NN
gene/NN
was/VBD
genotyped/VBN
by/IN
fragment/NN
analysis/NN
./.
====================
There/EX
was/VBD
no/DT
association/NN
between/IN
the/DT
2964A/NN
variant/JJ
and/CC
GT/NN
repeat/NN
polymorphism/NN
in/IN
exon/NN
1/CD
of/IN
the/DT
STAT6/NN
and/CC
allergic/JJ
rhinitis/NN
in/IN
a/DT
Korean/JJ
population/NN
(/(
both/CC
p/NN
>/JJR
0.05/CD
)/)
./.
====================
Our/PRP$
results/NNS
suggest/VBP
that/IN
a/DT
combination/NN
of/IN
STAT6/NN
gene/NN
polymorphisms/NNS
is/VBZ
not/RB
a/DT
useful/JJ
marker/NN
for/IN
predicting/VBG
allergic/JJ
rhinitis/NN
./.
====================
As/IN
allergic/JJ
diseases/NNS
are/VBP
multifactorial/JJ
diseases/NNS
,/,
the/DT
development/NN
of/IN
allergic/JJ
rhinitis/NN
appears/VBZ
to/TO
be/VB
determined/VBN
by/IN
the/DT
interaction/NN
between/IN
genetics/NNS
and/CC
environmental/JJ
exposure/NN
./.
====================
Interleukin/NN
(/(
IL/NN
)/)
-4/CD
and/CC
IL-13/NN
have/VBP
been/VBN
implicated/VBN
in/IN
the/DT
pathogenesis/NN
of/IN
allergic/JJ
rhinitis/NN
and/CC
====================
atopy/NN
./.
====================
These/DT
cytokines/NNS
are/VBP
produced/VBN
by/IN
T/NN
helper/NN
(/(
Th/NN
)/)
2/CD
cells/NNS
and/CC
are/VBP
capable/JJ
of/IN
inducing/VBG
isotype/NN
class-switching/VBG
of/IN
B/NN
cells/NNS
to/TO
produce/VB
lgE/NN
(/(
Howard/RB
et/FW
al./FW
,/,
2001/CD
)/)
./.
====================
IL-4/NN
and/CC
-13/CD
share/VBP
the/DT
IL-4/NN
receptor/NN
a/DT
chain/NN
as/IN
a/DT
common/JJ
receptor/NN
component/NN
and/CC
have/VBP
similar/JJ
biological/JJ
properties/NNS
(/(
Callard/JJ
etal./FW
,/,
1997/CD
)/)
./.
====================
Signal/NN
transducers/NNS
and/CC
activators/NNS
of/IN
transcription/NN
(/(
STAT/NN
)/)
proteins/NNS
are/VBP
a/DT
family/NN
of/IN
transcription/NN
factors/NNS
that/WDT
mediate/VBP
many/JJ
cytokine-induced/JJ
responses/NNS
(/(
lhle/JJ
,/,
1995/CD
)/)
./.
====================
STAT6/NN
is/VBZ
involved/VBN
in/IN
the/DT
IL-4/NN
and/CC
-13/CD
signaling/NN
pathway/NN
,/,
two/CD
cytokines/NNS
that/WDT
are/VBP
related/JJ
to/TO
allergic/JJ
diseases/NNS
(/(
Lin/JJ
et/FW
al./FW
,/,
1995/CD
)/)
./.
====================
STAT6-deficient/JJ
(/(
STAT6/NN
‘/CD
/_/NN
)/)
mice/NNS
fail/VBP
to/TO
develop/VB
IL-4-mediated/JJ
functions/NNS
,/,
including/VBG
Th2/NN
differentiation/NN
,/,
the/DT
expression/NN
of/IN
cell/NN
surface/NN
markers/NNS
,/,
and/CC
Ig/NN
class/NN
switching/NN
to/TO
IgE/NN
(/(
Kapan/NNP
et/FW
al./FW
,/,
1996/CD
;/:
Shimoda/NN
et/FW
al./FW
,/,
1996/CD
)/)
./.
====================
This/DT
finding/NN
demonstrates/VBZ
that/IN
STAT6/NN
activation/NN
is/VBZ
involved/VBN
in/IN
IL-4-/NN
and/CC
IL-13-mediated/JJ
disorders/NNS
,/,
such/JJ
as/IN
allergy/NN
./.
====================
The/DT
human/JJ
STAT6/NN
gene/NN
,/,
which/WDT
is/VBZ
approximately/RB
19/CD
kb/NN
long/JJ
,/,
is/VBZ
located/JJ
at/IN
12q13.3-q14.1/CD
and/CC
consists/VBZ
of/IN
23/CD
exons/NNS
(/(
Patel/NN
etal./FW
,/,
1998/CD
)/)
./.
====================
Exon/NN
1/CD
of/IN
the/DT
STAT6/NN
gene/NN
is/VBZ
a/DT
non-coding/JJ
region/NN
with/IN
GT/NN
repeat/NN
polymorphism/NN
that/WDT
might/MD
play/VB
an/DT
important/JJ
role/NN
in/IN
mRNA/NN
expression/NN
or/CC
mRNA/NN
stability/NN
(/(
Tamura/NN
et/FW
al./FW
,/,
2001/CD
)/)
./.
====================
If/IN
the/DT
GT/NN
repeat/NN
polymorphism/NN
influences/VBZ
such/JJ
regulatory/JJ
elements/NNS
directly/RB
or/CC
indirectly/RB
,/,
the/DT
consequence/NN
would/MD
be/VB
the/DT
abnormal/JJ
translation/NN
of/IN
the/DT
STAT6/NN
mRNA/NN
(/(
Duetsch/IN
etal/JJ
,/,
./.
====================
2002/CD
)/)
./.
====================
Recent/JJ
studies/NNS
identified/VBD
the/DT
polymorphisms/NNS
of/IN
exon/NN
1/CD
and/CC
a/DT
G2964A/NN
variant/JJ
of/IN
the/DT
STAT6/NN
gene/NN
in/IN
allergic/JJ
subjects/NNS
(/(
Tamura/NN
etal./FW
,/,
2001/CD
;/:
Gao/NNP
etal./FW
,/,
2000/CD
;/:
Tamura/NNP
et/FW
al./FW
,/,
2003/CD
)/)
./.
====================
Therefore/RB
,/,
we/PRP
tested/VBD
whether/IN
the/DT
STAT6/NN
gene/NN
polymorphisms/NNS
are/VBP
associated/VBN
with/IN
allergic/JJ
rhinitis/NN
in/IN
Korea/NN
./.
====================
And/CC
we/PRP
also/RB
investigated/VBD
the/DT
association/NN
between/IN
total/JJ
serum/NN
IgE/NN
levels/NNS
and/CC
blood/NN
eosinophil/NN
counts/NNS
and/CC
the/DT
STAT6/NN
gene/NN
polymorphisms/NNS
with/IN
allergic/JJ
rhinitis/NN
./.
====================
The/DT
distribution/NN
of/IN
the/DT
STAT6/NN
gene/NN
was/VBD
determined/VBN
in/IN
271/CD
healthy/JJ
subjects/NNS
(/(
138/CD
men/NNS
and/CC
133/CD
women/NNS
;/:
mean/JJ
age/NN
,/,
28.6/CD
±/CD
8.5/CD
years/NNS
)/)
and/CC
285/CD
patients/NNS
with/IN
allergic/JJ
rhinitis/NN
(/(
149/CD
men/NNS
and/CC
136/CD
women/NNS
;/:
mean/JJ
age/NN
,/,
26.9/CD
±/CD
12.3/CD
years/NNS
)/)
./.
====================
The/DT
patients/NNS
visited/VBD
our/PRP$
outpatient/JJ
clinic/NN
at/IN
Wonkwang/NNP
University/NN
Hospital/JJ
./.
====================
The/DT
diagnosis/NN
of/IN
allergic/JJ
rhinitis/NN
was/VBD
based/VBN
on/IN
clinical/JJ
symptoms/NNS
of/IN
sneezing/VBG
,/,
====================
watery/RB
rhinorrhea/NN
,/,
congestion/NN
,/,
and/CC
a/DT
positive/JJ
skin-prick/NN
test/NN
or/CC
multiple/JJ
allergen/NN
simultaneous/JJ
test/NN
(/(
MAST/NN
Immunosystems/NNS
,/,
CA/NN
,/,
USA/NN
)/)
./.
====================
Six/CD
common/JJ
aeroallergens/NNS
were/VBD
tested/VBN
:/:
house/RB
dust/IN
mites/NNS
(/(
Dermatophagoides/NNS
farinae/RB
,/,
Dermatophagoides/NNS
pteronyssinus/NN
)/)
,/,
house/RB
dust/IN
,/,
grass/JJ
mix/JJ
(/(
Bermuda/NNP
and/CC
Timothy/JJ
grass/JJ
)/)
,/,
tree/DT
pollens/NNS
(/(
box/NN
elder/JJ
,/,
hazelnut/RB
,/,
poplar/JJ
mix/JJ
,/,
ash/IN
mix/JJ
,/,
cedar/JJ
,/,
and/CC
birch/IN
)/)
,/,
animal/JJ
fur/RB
extracts/NNS
(/(
cat/NN
and/CC
dog/NN
dander/IN
)/)
,/,
and/CC
molds/NNS
(/(
Alternaria/FW
,/,
Cladosporium/NN
,/,
and/CC
Aspergillus/JJ
spp/RB
./.
)/)
./.
====================
All/DT
of/IN
the/DT
patients/NNS
diagnosed/VBD
with/IN
allergic/JJ
rhinitis/NN
had/VBD
a/DT
history/JJ
of/IN
all/DT
of/IN
the/DT
symptoms/NNS
and/CC
at/IN
least/JJS
one/CD
positive/JJ
allergy/NN
test/NN
./.
====================
We/PRP
carefully/RB
selected/VBN
healthy/JJ
control/NN
subjects/NNS
./.
====================
A/DT
detailed/JJ
questionnaire/NN
was/VBD
used/VBN
to/TO
select/VB
subjects/NNS
who/WP
had/VBD
no/DT
family/NN
history/NN
of/IN
atopy/NN
./.
====================
All/DT
of/IN
the/DT
control/NN
subjects/NNS
were/VBD
negative/JJ
for/IN
allergic/JJ
symptoms/NNS
and/CC
had/VBD
negative/JJ
results/NNS
on/IN
allergy/NN
testing/NN
./.
====================
Informed/VBN
consent/JJ
was/VBD
obtained/VBN
from/IN
all/DT
of/IN
the/DT
patients/NNS
and/CC
control/NN
subjects/NNS
,/,
and/CC
the/DT
protocols/NNS
were/VBD
approved/VBN
by/IN
the/DT
Committee/NN
of/IN
Ethics/NNS
,/,
Faculty/NN
of/IN
Medicine/NN
,/,
Wonkwang/NNP
University/NN
./.
====================
DNA/NN
was/VBD
extracted/VBN
from/IN
peripheral/JJ
blood/NN
leukocytes/NNS
./.
====================
The/DT
dinucleotide/NN
repeat/NN
polymorphism/NN
of/IN
the/DT
first/JJ
exon/NN
of/IN
the/DT
STAT6/NN
gene/NN
was/VBD
genotyped/VBN
as/IN
previously/RB
described/VBN
(/(
Tamura/NN
et/FW
al./FW
,/,
2001/CD
)/)
./.
====================
The/DT
G2964A/NN
variant/JJ
of/IN
the/DT
STAT6/NN
gene/NN
was/VBD
genotyped/VBN
using/VBG
PCR-RFLP/NN
./.
====================
PCR/NN
primer/NN
sets/NNS
were/VBD
designed/VBN
to/TO
amplify/VB
fragments/NNS
containing/VBG
each/DT
polymorphism/NN
./.
====================
PCR/NN
was/VBD
performed/VBN
in/IN
a/DT
volume/NN
of/IN
20/CD
pl/NN
containing/VBG
50/CD
ng/NN
of/IN
genomic/JJ
DNA/NN
,/,
125/CD
pmol/NN
of/IN
each/DT
dNTP/NN
,/,
1/CD
U/NNP
of/IN
Taq/NN
polymerase/NN
,/,
Taq/NN
buffer/NN
,/,
and/CC
10/CD
pmol/NN
of/IN
the/DT
forward/JJ
and/CC
reverse/JJ
primers/NNS
./.
====================
For/IN
STAT6/NN
exon/NN
1/CD
,/,
a/DT
6-FAM-labled/JJ
forward/JJ
primer/NN
was/VBD
used/VBN
./.
====================
The/DT
cycle/NN
conditions/NNS
were/VBD
95°C/JJ
for/IN
5/CD
min/NN
,/,
and/CC
then/RB
35/CD
cycles/NNS
of/IN
95°C/JJ
for/IN
30/CD
s/NNS
,/,
62°C/NNP
(/(
STAT6/NN
exon/NN
1/CD
)/)
or/CC
55°C/JJ
(/(
G2964A/NN
variant/JJ
)/)
for/IN
30/CD
s/NNS
,/,
and/CC
72°C/JJ
for/IN
40/CD
s/NNS
,/,
with/IN
a/DT
final/JJ
7/CD
min/NN
at/IN
72°C/JJ
,/,
in/IN
a/DT
PTC-200/NN
Peltier-effect/JJ
thermal/JJ
cycler/NN
(/(
MJ/NNP
Research/NNP
,/,
MA/NN
,/,
USA/NNP
)/)
./.
====================
The/DT
285/CD
subjects/NNS
with/IN
allergic/JJ
rhinitis/NN
and/CC
271/CD
controls/NNS
were/VBD
genotyped/VBN
in/IN
terms/NNS
of/IN
the/DT
GT/NN
repeat/NN
polymorphism/NN
in/IN
====================
exon/NN
1/CD
of/IN
the/DT
STAT6/NN
gene/NN
./.
====================
After/IN
PCR/NN
,/,
1/CD
/d/NN
of/IN
the/DT
products/NNS
plus/CC
0.5/CD
p\/NN
of/IN
the/DT
GeneScan/NN
500/CD
ROX/NN
size/NN
standard/JJ
(/(
Applied/VBN
Biosystems/NNS
,/,
Warrington/NNP
,/,
UK/NN
)/)
were/VBD
denatured/VBN
in/IN
12/CD
of/IN
formamide/JJ
and/CC
separated/VBN
in/IN
an/DT
Applied/JJ
Biosystems/NNS
Prism/NN
Genetic/JJ
Analyzer/NN
(/(
ABI/LS
PRISM/NN
'/``
m/NN
3100/CD
)/)
with/IN
POP4/NN
polymer/NN
;/:
then/RB
the/DT
fragment/NN
lengths/NNS
were/VBD
determined/VBN
./.
====================
The/DT
polymorphic/JJ
PCR/NN
products/NNS
were/VBD
classified/VBN
into/IN
four/CD
alleles/NNS
:/:
A1/NN
(/(
352/CD
bp/NN
,/,
13GT/NN
repeats/NNS
)/)
to/TO
A4/NN
(/(
358/CD
bp/NN
,/,
16GT/NN
repeats/NNS
)/)
(/(
Table/JJ
1/CD
)/)
./.
====================
The/DT
forward/JJ
and/CC
reverse/JJ
primers/NNS
used/VBN
for/IN
STAT6/NN
exon/NN
1/CD
were/VBD
5'gagggggacagagtaagtggg3/JJ
'/``
and/CC
5'gctagcacctcccccctt3/NN
'/``
,/,
respectively/RB
./.
====================
The/DT
G2964A/NN
polymorphism/NN
in/IN
the/DT
3/CD
'/``
untranslated/JJ
region/NN
of/IN
the/DT
STAT6/NN
gene/NN
(/(
NCBI/NN
SNP/NN
Cluster/NN
ID/NN
:/:
rs324015/CD
)/)
was/VBD
determined/VBN
by/IN
PCR/NN
and/CC
the/DT
amplification-/NN
created/VBD
restriction/NN
site/NN
method/NN
according/VBG
to/TO
Amoli/FW
et/FW
a//FW
(/(
Amoli/FW
et/FW
al./FW
,/,
2000/CD
)/)
./.
====================
The/DT
forward/JJ
and/CC
reverse/JJ
primers/NNS
used/VBN
were/VBD
5/CD
’/NN
gaagttcaggctctgagac3/NN
'/``
and/CC
S'ccatcaccctcagagagcS/NN
'/``
,/,
respectively/RB
./.
====================
The/DT
PCR/NN
product/NN
of/IN
the/DT
93-bp/JJ
band/NN
was/VBD
mixed/VBN
with/IN
3/CD
U/NNP
of/IN
BsaHI/NN
(/(
New/NN
England/NN
Biolabs/NNS
,/,
Beverly/RB
,/,
MA/NN
,/,
USA/NNP
)/)
and/CC
the/DT
reaction/NN
buffer/NN
,/,
according/VBG
to/TO
the/DT
manufacturer/NN
’/CD
s/NNS
instructions/NNS
./.
====================
The/DT
digestion/NN
with/IN
BsaHI/NN
yielded/VBD
74-/CD
and/CC
19-bp/JJ
fragments/NNS
when/WRB
there/EX
was/VBD
a/DT
G/NN
at/IN
position/NN
2964/CD
./.
====================
The/DT
reaction/NN
was/VBD
incubated/VBN
at/IN
37°C/NN
for/IN
5/CD
h/NN
;/:
10/CD
•/NN
I/NN
of/IN
the/DT
product/NN
was/VBD
loaded/VBN
onto/IN
a/DT
4.5/CD
%/NN
agarose/IN
gel/NN
containing/VBG
ethidium/NN
bromide/NN
,/,
for/IN
electrophoresis/NN
./.
====================
Individuals/NNS
homozygous/JJ
for/IN
the/DT
rare/JJ
allele/NN
(/(
allele/NN
2964A/NN
)/)
yielded/VBD
one/CD
uncut/JJ
band/NN
(/(
93/CD
bp/NN
)/)
./.
====================
The/DT
2964G/NN
allele/NN
yielded/VBD
two/CD
bands/NNS
of/IN
74/CD
and/CC
19/CD
bp/NN
./.
====================
Serum/NN
levels/NNS
of/IN
total/JJ
IgE/NN
were/VBD
determined/VBN
by/IN
using/VBG
the/DT
electrochemiluminescence/NN
immunoassay/NN
(/(
EVO/NN
,/,
Roche/NNP
Diagnostics/NNS
GmbH/NN
,/,
Mannheim/JJ
,/,
Germany/NNP
)/)
./.
====================
Eosinophil/NN
values/NNS
were/VBD
determined/VBN
by/IN
the/DT
eosinophil/NN
numbers/NNS
per/IN
total/JJ
cell/NN
numbers/NNS
per/IN
pH/NN
./.
====================
A/DT
reading/NN
of/IN
more/RBR
than/IN
100/CD
lU/mL/NN
total/JJ
IgE/NN
was/VBD
considered/VBN
as/IN
atopy/NN
./.
====================
The/DT
normal/JJ
range/NN
of/IN
blood/NN
eosinophil/NN
counts/NNS
was/VBD
40-500//^/CD
./.
====================
The/DT
genotypes/NNS
and/CC
allele/NN
frequencies/NNS
of/IN
the/DT
STAT6/NN
====================
gene/NN
polymorphisms/NNS
in/IN
the/DT
controls/NNS
and/CC
patients/NNS
were/VBD
====================
compared/VBN
using/VBG
Pearson/JJ
’/CD
s/NNS
two-tailed/JJ
chi-squared/JJ
test/NN
(/(
SPSS/NN
10.0/CD
,/,
SPSS/NN
Inc./NNP
,/,
Chicago/JJ
,/,
IL/NN
)/)
./.
====================
The/DT
standard/JJ
analysis/NN
of/IN
variance/NN
(/(
ANOVA/NN
)/)
test/NN
for/IN
quantitative/JJ
traits/VBZ
was/VBD
used/VBN
to/TO
compare/VB
levels/NNS
of/IN
serum/NN
total/JJ
IgE/NN
and/CC
blood/NN
eosinophil/NN
counts/NNS
./.
====================
A/DT
p-value/JJ
less/RBR
than/IN
0.05/CD
was/VBD
considered/VBN
statistically/RB
significant/JJ
./.
====================
The/DT
Hardy-Weinberg/JJ
equilibrium/NN
was/VBD
determined/VBN
using/VBG
the/DT
x/NN
2/CD
goodness-of-fit/NN
test/NN
./.
====================
The/DT
distribution/NN
of/IN
the/DT
GT/NN
repeat/NN
polymorphism/NN
of/IN
STAT6/NN
exon/NN
1/CD
is/VBZ
shown/VBN
in/IN
Table/JJ
1/CD
./.
====================
The/DT
distribution/NN
of/IN
the/DT
four/CD
alleles/NNS
(/(
13-/CD
,/,
14-/CD
,/,
15-/CD
,/,
and/CC
16GT/NN
repeat/NN
alleles/NNS
)/)
is/VBZ
shown/VBN
./.
====================
The/DT
15/15GT/NN
genotype/NN
occurred/VBD
most/JJS
frequently/RB
in/IN
the/DT
allergic/JJ
rhinitis/NN
and/CC
control/NN
groups/NNS
./.
====================
The/DT
next/JJ
most/JJS
frequent/JJ
was/VBD
13/15GT/NN
in/IN
both/CC
groups/NNS
./.
====================
Although/IN
these/DT
two/CD
genotypes/NNS
were/VBD
more/RBR
frequent/JJ
in/IN
the/DT
control/NN
group/NN
,/,
the/DT
difference/NN
was/VBD
not/RB
statistically/RB
significant/JJ
(/(
p/NN
>/JJR
0.05/CD
)/)
./.
====================
There/EX
was/VBD
no/DT
13/17GT/NN
or/CC
16/16GT/NN
genotype/NN
in/IN
the/DT
allergic/JJ
rhinitis/NN
group/NN
,/,
whereas/IN
there/EX
was/VBD
no/DT
15/17GT/NN
genotype/NN
in/IN
the/DT
control/NN
group/NN
./.
====================
None/NN
of/IN
the/DT
GT-repeat/NN
====================
alleles/NNS
of/IN
the/DT
patients/NNS
with/IN
allergic/JJ
rhinitis/NN
were/VBD
significantly/RB
different/JJ
from/IN
those/DT
of/IN
the/DT
control/NN
group/NN
(/(
p/NN
>/JJR
0.05/CD
)/)
./.
====================
Table/JJ
2/CD
shows/VBZ
the/DT
distribution/NN
of/IN
the/DT
G2964A/NN
variant/JJ
of/IN
the/DT
STAT6/NN
gene/NN
./.
====================
The/DT
genotypes/NNS
of/IN
the/DT
allergic/JJ
rhinitis/NN
group/NN
were/VBD
not/RB
significantly/RB
different/JJ
from/IN
those/DT
of/IN
the/DT
control/NN
group/NN
(/(
p/NN
>/JJR
0.05/CD
)/)
./.
====================
The/DT
mutant/JJ
A/NN
allele/NN
was/VBD
predominant/JJ
in/IN
both/CC
groups/NNS
./.
====================
Moreover/RB
,/,
the/DT
frequency/NN
of/IN
the/DT
A/NN
allele/NN
in/IN
the/DT
allergic/JJ
rhinitis/NN
group/NN
was/VBD
not/RB
significantly/RB
different/JJ
from/IN
that/DT
of/IN
the/DT
control/NN
group/NN
(/(
p/NN
>/JJR
0.05/CD
)/)
./.
====================
There/EX
was/VBD
no/DT
significant/JJ
difference/NN
in/IN
either/CC
mean/NN
total/JJ
serum/NN
IgE/NN
levels/NNS
or/CC
blood/NN
eosinophil/NN
counts/NNS
between/IN
the/DT
genotype/NN
of/IN
G2964A/NN
of/IN
the/DT
STAT6/NN
gene/NN
(/(
Table/JJ
3/CD
)/)
./.
====================
And/CC
also/RB
there/EX
was/VBD
no/DT
significant/JJ
difference/NN
in/IN
mean/JJ
blood/NN
eosinophil/NN
counts/NNS
between/IN
the/DT
distribution/NN
of/IN
GT/NN
repeat/NN
polymorphism/NN
of/IN
STAT6/NN
exon/NN
1/CD
(/(
Table/JJ
4/CD
)/)
./.
====================
The/DT
hereditary/JJ
character/NN
of/IN
allergic/JJ
rhinitis/NN
and/CC
other/JJ
====================
atopic/JJ
diseases/NNS
has/VBZ
been/VBN
shown/VBN
in/IN
studies/NNS
of/IN
families/NNS
and/CC
twins/NNS
(/(
Edfors-Lubs/NNS
etal./FW
,/,
1971/CD
)/)
./.
====================
Twin/NN
studies/NNS
have/VBP
confirmed/VBN
the/DT
hereditary/JJ
transmission/NN
of/IN
atopy/NN
./.
====================
The/DT
concordance/NN
of/IN
allergy/NN
in/IN
monozygotic/JJ
,/,
genetically/RB
identical/JJ
twins/NNS
is/VBZ
higher/JJR
than/IN
in/IN
dizygotic/JJ
twins/NNS
(/(
Edfors-Lubs/NNS
et/FW
al./FW
,/,
1971/CD
)/)
./.
====================
The/DT
estimated/VBN
heritability/NN
of/IN
allergic/JJ
diseases/NNS
is/VBZ
50-60/CD
%/NN
based/VBN
on/IN
twin/NN
studies/NNS
and/CC
segregation/NN
analyses/NNS
(/(
Palmer/NN
etal./FW
,/,
2000/CD
)/)
./.
====================
The/DT
genetics/NNS
of/IN
allergic/JJ
rhinitis/NN
have/VBP
not/RB
been/VBN
studied/VBN
as/IN
well/RB
as/IN
those/DT
of/IN
asthma/NN
and/CC
atopy/NN
./.
====================
Although/IN
much/RB
effort/NN
has/VBZ
been/VBN
spent/JJ
attempting/VBG
to/TO
dissect/VB
complex/NN
diseases/NNS
genetically/RB
,/,
the/DT
genetics/NNS
of/IN
these/DT
diseases/NNS
seem/VBP
to/TO
be/VB
more/RBR
complicated/VBN
than/IN
initially/RB
thought/VBN
./.
====================
Some/DT
genetic/JJ
linkages/NNS
have/VBP
been/VBN
demonstrated/VBN
using/VBG
molecular/JJ
markers/NNS
located/JJ
in/IN
and/CC
around/IN
genes/NNS
whose/WP$
products/NNS
are/VBP
involved/VBN
in/IN
the/DT
pathophysiology/NN
of/IN
atopy/NN
or/CC
are/VBP
spread/VBN
throughout/IN
the/DT
genome/NN
(/(
Bleecker/NN
et/FW
al./FW
,/,
1998/CD
;/:
Wilkinson/NNP
et/FW
al./FW
,/,
1999/CD
)/)
./.
====================
Single/JJ
nucleotide/NN
polymorphisms/NNS
are/VBP
the/DT
most/JJS
common/JJ
variation/NN
in/IN
the/DT
DNA/NN
sequence/NN
and/CC
are/VBP
present/JJ
at/IN
a/DT
frequency/NN
of/IN
about/RB
1/CD
in/IN
1,000/CD
nucleotides/NNS
in/IN
humans/NNS
(/(
Kruglyak/JJ
L/NN
etal./FW
,/,
2001/CD
)/)
./.
====================
Recent/JJ
studies/NNS
reported/VBD
the/DT
linkage/NN
and/CC
association/NN
between/IN
two/CD
STAT6/NN
gene/NN
polymorphisms—the/DT
GT/NN
repeat/NN
polymorphism/NN
in/IN
exon/NN
1/CD
and/CC
the/DT
G2964A/NN
variant/JJ
of/IN
the/DT
STAT6/NN
gene-and/CC
allergic/JJ
diseases/NNS
(/(
Tamura/NN
K/NN
et/FW
al./FW
,/,
2001/CD
;/:
Gao/NNP
etal./FW
,/,
2000/CD
;/:
Tamura/NNP
etal./FW
,/,
2003/CD
)/)
./.
====================
Tamura/NN
et/FW
al/JJ
./.
====================
(/(
2001/CD
)/)
showed/VBD
that/IN
the/DT
genotypes/NNS
of/IN
the/DT
13/15GT/NN
repeat/NN
heterozygosity/NN
and/CC
15GT/NN
homozygosity/NN
in/IN
exon/NN
1/CD
of/IN
STAT6/NN
were/VBD
significantly/RB
associated/VBN
with/IN
allergic/JJ
rhinitis/NN
./.
====================
They/PRP
suggested/VBD
that/IN
the/DT
dinucleotide/NN
repeat/NN
polymorphism/NN
identified/VBN
in/IN
their/PRP$
study/NN
represents/VBZ
a/DT
marker/NN
mutation/NN
,/,
or/CC
might/MD
be/VB
genetically/RB
linked/VBN
to/TO
another/DT
polymorphism/NN
associated/VBN
with/IN
the/DT
development/NN
of/IN
allergic/JJ
disease/NN
,/,
such/JJ
as/IN
atopic/JJ
dermatitis/NN
,/,
bronchial/JJ
asthma/NN
,/,
or/CC
food-related/VBN
anaphylaxis/NN
./.
====================
In/IN
a/DT
case-control/JJ
study/NN
conducted/VBD
in/IN
British/JJ
and/CC
Japanese/JJ
adults/NNS
,/,
Gao/NNP
et/FW
al/JJ
./.
====================
(/(
2000/CD
)/)
found/VBD
no/DT
association/NN
between/IN
the/DT
STAT6/NN
2964A/NN
variant/JJ
and/CC
adult/JJ
asthmatic/JJ
subjects/NNS
in/IN
a/DT
British/JJ
population/NN
,/,
but/CC
found/VBD
an/DT
association/NN
with/IN
adult/JJ
atopic/JJ
mild/JJ
asthmatic/JJ
subjects/NNS
in/IN
a/DT
Japanese/JJ
population/NN
./.
====================
Two/CD
different/JJ
case-control/JJ
studies/NNS
of/IN
atopic/JJ
asthma/NN
in/IN
Japanese/JJ
populations/NNS
found/VBN
different/JJ
results/NNS
for/IN
the/DT
association/NN
between/IN
this/DT
SNP/NN
and/CC
allergic/JJ
diseases/NNS
(/(
Gao/NNP
et/FW
al./FW
,/,
2000/CD
;/:
Tamura/NN
et/FW
al./FW
,/,
2003/CD
)/)
./.
====================
These/DT
findings/NNS
suggest/VBP
that/IN
there/EX
are/VBP
marked/JJ
differences/NNS
not/RB
only/RB
between/IN
different/JJ
ethnic/JJ
groups/NNS
but/CC
also/RB
within/IN
one/CD
ethnic/JJ
group/NN
,/,
underlining/VBG
the/DT
genetic/JJ
heterogeneity/NN
of/IN
complex/NN
diseases/NNS
like/IN
allergic/JJ
diseases/NNS
./.
====================
We/PRP
found/VBD
no/DT
associations/NNS
between/IN
the/DT
2964A/NN
variant/JJ
and/CC
the/DT
GT/NN
repeat/NN
polymorphism/NN
in/IN
exon/NN
1/CD
of/IN
STAT6/NN
and/CC
allergic/JJ
rhinitis/NN
in/IN
a/DT
Korean/JJ
population/NN
./.
====================
Ethnic/JJ
differences/NNS
are/VBP
well/RB
documented/VBN
to/TO
play/VB
a/DT
major/JJ
role/NN
in/IN
association/NN
====================
studies/NNS
,/,
thus/RB
it/PRP
is/VBZ
important/JJ
to/TO
verify/VB
and/CC
identify/VBP
polymorphisms/NNS
in/IN
the/DT
particular/JJ
population/NN
under/IN
study/NN
./.
====================
Several/JJ
previous/JJ
studies/NNS
have/VBP
suggested/VBN
that/IN
there/EX
are/VBP
significant/JJ
interethnic/JJ
differences/NNS
in/IN
the/DT
allele/NN
frequencies/NNS
of/IN
atopy/NN
predisposition/NN
genotypes/NNS
among/IN
Asians/NNS
compared/VBN
with/IN
the/DT
Caucasian/JJ
population/NN
(/(
Kim/NN
et/FW
al./FW
,/,
2004/CD
;/:
Lee/NNP
et/FW
al./FW
,/,
2004/CD
;/:
Yao/NNP
et/FW
al./FW
,/,
2003/CD
;/:
Kim/NN
etal./FW
,/,
2004/CD
)/)
./.
====================
In/IN
a/DT
recent/JJ
study/NN
of/IN
the/DT
G2964A/NN
variant/JJ
,/,
the/DT
G/NN
allele/NN
was/VBD
dominant/JJ
in/IN
Caucasians/NNS
(/(
Gao/NNP
et/FW
al./FW
,/,
2000/CD
)/)
./.
====================
By/IN
contrast/NN
,/,
the/DT
A/NN
allele/NN
was/VBD
dominant/JJ
in/IN
our/PRP$
(/(
Korean/JJ
)/)
and/CC
another/DT
(/(
Japanese/JJ
)/)
(/(
Gao/NNP
et/FW
al./FW
,/,
2000/CD
)/)
study/NN
population/NN
(/(
i.e./FW
,/,
Korean/JJ
:/:
57/CD
%/NN
,/,
Japanese/JJ
:/:
67/CD
%/NN
,/,
Caucasian/JJ
:/:
24/CD
%/NN
)/)
./.
====================
These/DT
findings/NNS
suggest/VBP
genetic/JJ
heterogeneity/NN
between/IN
Asian/JJ
and/CC
Western/NN
populations/NNS
./.
====================
An/DT
elevated/JJ
total/JJ
serum/NN
IgE/NN
is/VBZ
seen/VBN
in/IN
disorders/NNS
related/JJ
to/TO
atopy/NN
,/,
such/JJ
as/IN
asthma/NN
and/CC
allergic/JJ
rhinitis/NN
./.
====================
A/DT
genetic/JJ
linkage/NN
has/VBZ
been/VBN
reported/VBN
between/IN
the/DT
total/JJ
IgE/NN
level/NN
and/CC
the/DT
region/NN
on/IN
chromosome/NN
5q31-33/NN
encoding/VBG
a/DT
cluster/NN
of/IN
cytokine/NN
genes/NNS
(/(
Meyers/NNS
et/FW
al./FW
,/,
1994/CD
)/)
./.
====================
We/PRP
investigated/VBD
the/DT
relationships/NNS
between/IN
the/DT
eosinophil/NN
count/NN
and/CC
total/JJ
serum/NN
immunoglobulin/NN
E/NN
(/(
IgE/NN
)/)
level/NN
and/CC
the/DT
genotypes/NNS
of/IN
the/DT
GT/NN
repeat/NN
polymorphism/NN
in/IN
exon/NN
1/CD
and/CC
the/DT
G2964A/NN
variant/JJ
of/IN
the/DT
STAT6/NN
gene/NN
in/IN
allergic/JJ
rhinitis/NN
patients/NNS
,/,
but/CC
could/MD
not/RB
find/VB
any/DT
significant/JJ
associations/NNS
./.
====================
To/TO
the/DT
best/JJS
of/IN
our/PRP$
knowledge/NN
,/,
this/DT
report/NN
is/VBZ
the/DT
first/JJ
study/NN
of/IN
STAT6/NN
gene/NN
polymorphisms/NNS
in/IN
allergic/JJ
rhinitis/NN
in/IN
a/DT
Korean/JJ
population/NN
./.
====================
Our/PRP$
results/NNS
indicate/VBP
that/IN
a/DT
combination/NN
of/IN
STAT6/NN
gene/NN
polymorphisms/NNS
may/MD
not/RB
be/VB
a/DT
useful/JJ
marker/NN
for/IN
predicting/VBG
allergic/JJ
rhinitis/NN
in/IN
a/DT
Korean/JJ
population/NN
./.
====================
Larger/NN
,/,
population-based/VBD
studies/NNS
are/VBP
necessary/JJ
to/TO
confirm/VB
the/DT
association/NN
of/IN
this/DT
genetic/JJ
marker/NN
with/IN
allergic/JJ
rhinitis/NN
in/IN
Koreans/NNS
./.
====================
The/DT
identification/NN
and/CC
understanding/NN
of/IN
allergic/JJ
disease-specific/JJ
genes/NNS
,/,
their/PRP$
expression/NN
,/,
and/CC
their/PRP$
proteins/NNS
may/MD
lead/VB
to/TO
the/DT
development/NN
of/IN
individually/RB
tailored/VBN
treatment/NN
regimens/NNS
that/DT
specifically/RB
manipulate/VBP
the/DT
immune/JJ
system/NN
of/IN
the/DT
individual/JJ
being/VBG
treated/VBN
./.
====================
T/NN
helper-type/NN
2/CD
cytokines/NNS
,/,
such/JJ
as/IN
IL-4/NN
and/CC
IL-13/NN
,/,
may/MD
play/VB
a/DT
central/JJ
role/NN
in/IN
allergic/JJ
diseases/NNS
./.
====================
The/DT
protein/NN
known/VBN
as/IN
signal/JJ
transducers/NNS
and/CC
activators/NNS
of/IN
transcription/NN
6/CD
(/(
STAT6/NN
)/)
is/VBZ
a/DT
key/JJ
transcription/NN
factor/NN
involved/VBN
in/IN
both/DT
IL-4-/NN
and/CC
-13-mediated/JJ
biological/JJ
responses/NNS
./.
====================
Two/CD
polymorphisms/NNS
of/IN
the/DT
STAT/NN
6/CD
gene/NN
(/(
exon/NN
1/CD
and/CC
G2964A/NN
variant/JJ
)/)
have/VBP
been/VBN
found/VBN
./.
====================
Our/PRP$
results/NNS
indicate/VBP
that/IN
a/DT
combination/NN
of/IN
STAT6/NN
gene/NN
polymorphisms/NNS
may/MD
not/RB
be/VB
a/DT
useful/JJ
marker/NN
for/IN
predicting/VBG
allergic/JJ
rhinitis/NN
in/IN
a/DT
Korean/JJ
population/NN
./.
====================
